Replies to post #1809 on Biotech Values

[DewDiligence]

>> Your overlooking something that weighs much higher than a drop out rate in single digets no matter if it's CJC or whoever. That's the size of the market and the humongous number of pts. <<

Believe me, I am not overlooking the size of the diabetes market (see #msg-1995557). But a big potential market doesn’t magically turn fair clinical data into great clinical data.